| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.170 | None | 1.000 | 0 | 0 | 2016 | 2020 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
disease | 0.110 | None | 1.000 | 0 | 1 | 2016 | 2016 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.110 | None | 1.000 | 0 | 0 | 2016 | 2016 | ||||||||
|
mitogen-activated protein kinase 1 | 0.330 | 0.923 | 1.00 |
|
disease | 0.170 | None | 1.000 | 0 | 0 | 2001 | 2019 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
cytochrome c oxidase subunit II | 0.352 | 0.962 |
|
disease | 0.470 | None | 1.000 | 0 | 0 | 2002 | 2019 | |||||||||
|
fibroblast growth factor receptor 1 | 0.362 | 0.885 | 1.00 |
|
disease | 0.620 | None | 1.000 | 0 | 0 | 2003 | 2018 | ||||||||
|
superoxide dismutase 1 | 0.379 | 0.962 | 0.18 |
|
disease | 0.620 | None | 1.000 | 0 | 0 | 1999 | 2019 | ||||||||
|
solute carrier family 2 member 1 | 0.388 | 0.808 | 0.99 |
|
disease | 0.120 | None | 1.000 | 0 | 0 | 2016 | 2019 | ||||||||
|
mutL homolog 1 | 0.399 | 0.808 | 3.4E-05 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
catechol-O-methyltransferase | 0.400 | 0.923 | 1.1E-06 |
|
disease | 0.500 | None | 1.000 | 0 | 0 | 1983 | 2019 | ||||||||
|
protein kinase cAMP-dependent type I regulatory subunit alpha | 0.401 | 0.846 | 1.00 |
|
disease | 0.110 | None | 1.000 | 0 | 0 | 2018 | 2018 | ||||||||
|
programmed cell death 1 | 0.402 | 0.846 | 0.42 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
DNA methyltransferase 1 | 0.406 | 0.885 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
mutS homolog 2 | 0.406 | 0.808 | 0.90 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
major histocompatibility complex, class II, DQ beta 1 | 0.407 | 0.885 | 8.9E-03 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
paraoxonase 1 | 0.409 | 0.885 | 9.8E-11 |
|
disease | 0.470 | None | 1.000 | 0 | 0 | 2007 | 2019 | ||||||||
|
calcium sensing receptor | 0.410 | 0.846 | 4.7E-02 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
transforming growth factor beta receptor 2 | 0.413 | 0.846 | 0.13 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
methyl-CpG binding protein 2 | 0.414 | 0.846 | 0.89 |
|
disease | 0.130 | None | 1.000 | 0 | 0 | 2015 | 2018 | ||||||||
|
elastin | 0.415 | 0.885 | 2.1E-14 |
|
disease | 0.110 | None | 1.000 | 0 | 0 | 2019 | 2019 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 1 | 0.416 | 0.846 | 2.4E-02 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
platelet derived growth factor receptor beta | 0.416 | 0.846 | 0.90 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
GNAS complex locus | 0.420 | 0.885 | 0.68 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
synuclein alpha | 0.427 | 0.885 | 0.88 |
|
disease | 0.200 | None | 1.000 | 0 | 0 | 2008 | 2019 |